Carbamazepine-nefazodone interaction in healthy subjects

Journal of Clinical Psychopharmacology

Volumn 20, Issue 1, 2000, Pages 46-53

  Laroudie, Cécile ^a   Salazar, Daniel E ^a   Cosson, Jean Philippe ^a,c   Cheuvart, Brigitte ^a   Istin, Bertrand ^b   Girault, Jacques ^b   Ingrand, Isabelle ^b   Decourt, Jean Philippe ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b Ctr de Rech Biomedicale CEMAF   (France)

^c La Grande Arche Nord ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; DRUG METABOLITE; HYDROXYNEFAZODONE; NEFAZODONE; TRIAZOLE DERIVATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MIXTURE; DRUG MONITORING; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FEVER; HEADACHE; HUMAN; HUMAN EXPERIMENT; MALE; MYALGIA; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; SOMNOLENCE; VISUAL IMPAIRMENT;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIMANIC AGENTS; AREA UNDER CURVE; CARBAMAZEPINE; CYTOCHROME P-450 CYP2D6; DRUG INTERACTIONS; HUMANS; MALE; TRIAZOLES;

EID: 0033977377     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200002000-00009     Document Type: Article

References (40)

1. Rickels K, Schweizer E, Clary C, Fox I, Weise C. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164:802-5.
2. Fontaine R, Ontiveros A, Elie R, Kensler TT, Roberts DL, Kaplita S, Ecker JA, Faludi G. A double-blind comparison of nefazodone, imipramine and placebo in major depression. J Clin Psychiatry 1994;55:234-41.
3. Anton SF, Robinson DS, Roberts DL, Kensler TT, English PA, Archibald DG. Long-term treatment of depression with nefazodone. Psychopharmacol Bull 1994;30:165-9.
4. Taylor DP, Eison MS, Riblet LA, Temple DL, Yevich JP, Smith DW. Selective 5-HT receptor blockade: pharmacologic studies of BMY13754, a nontricyclic antidepressant candidate [abstract]. Soc Neurosci Abstr 1982;8:465.
5. Mayol RF, Cole CA, Luke GM, Colson KL, Kerns EH. Characterization of the metabolites of antidepressant drug nefazodone in human urine and plasma. Drug Metab Dispos 1994;22:304-11.
6. Barbhaiya RH, Marathe PH, Greene DS, Mayol RF, Shukla UA, Gammans RR, Pittman KA, Robinson D. Safety, tolerance and preliminary pharmacokinetics of nefazodone after administration of single and multiple oral doses to healthy adult male volunteers: a double-blind, phase I study. J Clin Pharmacol 1995;35:974-84.
7. Kaul S, Shukla UA, Barbhaiya RH. Nonlinear pharmacokinetics of nefazodone after escalating single and multiple oral doses. J Clin Pharmacol 1995;35:830-4.
8. Marathe PH, Lee JS, Greene DS, Barbhaiya RH. Comparison of the steady-state pharmacokinetics of nefazodone after administration of 200 mg twice daily or 400 mg once daily in the morning or evening. Br J Clin Pharmacol 1996;41:21-7.
9. Schmider J, Greenblatt DJ, Von Molkte LL, Harmatz JS, Shader RI. Inhibition of cytochrome P450 by nefazodone in vitro: studies of dextromethorphan O- and N-demethylation. Br J Clin Pharmacol 1996;41:339-43.
10. von Moltke LL, Greenblatt DJ, Harmatz JS, Duan SX, Harrel LM, Cotreau-Bibbo MM, Pritchard GA, Wright CE, Shader RI. Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole. J Pharmacol Exp Ther 1996;276:370-9.
11. Barbhaiya RH, Shukla UA, Kroboth PD, Greene DS. Coadministration of nefazodone and benzodiazepines: II. A pharmacokinetic interaction study with triazolam. J Clin Psychopharmacol 1995;15:320-6.
12. Greene DS, Salazar DE, Dockens RC, Kroboth PD, Barbhaiya RH. Co-administration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam. J Clin Psychopharmacol 1995;15:399-407.
13. Birkhimmer LJ, Curtis JL, Jann MW. Use of carbamazepine in psychiatric disorders. Clin Pharm 1985;4:435-44.
14. Israel M, Beaudry P. Carbamazepine in psychiatry: a review. Can J Psychiatry 1988;33:577-84.
15. Post RM, Weiss SRB, Chuang DM, Keter TA. Mechanism of action of carbamazepine in seizure and affective disorders. In: Joffre RT, Calabrese JR, eds. Anticonvulsants in psychiatry. New York: Marcel Dekker, 1994:43-92.
16. Tomson T, Tybring G, Bertilsson L. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide. Clin Pharmacol Ther 1983;33:58-65.
17. Bertilsson L, Tomson T, Tybring G. Pharmacokinetics: time-dependent changes - autoinduction of carbamazepine epoxidation. J Clin Pharmacol 1986;26:459-62.
18. Kerr BM, Thummel KE, Wurden CJ, Klein SM, Kroetz DL, Gonzales FJ, Levy RH. Human liver carbamazepine metabolism: role of CYP3A4 and CYP2C8 in 10,11-epoxide formation. Biochem Pharmacol 1994;47:1969-79.
19. Levy RH, Kerr BM. Clinical pharmacokinetics of carbamazepine. J Clin Psychiatry 1988;49:58-61.
20. Ketter TA, Post RM, Worthington K. Principles of clinically important drug interactions with carbamazepine. Part I. J Clin Psychopharmacol 1991;11:198-203.
21. Ketter TA, Post RM, Worthington K. Principles of clinically important drug interactions with carbamazepine. Part II. J Clin Psychopharmacol 1991;11:306-13.
22. Pisani F, Fazio A, Oteri G, Perucca E, Russo M, Trio R, Pisani B, Di Perri R. Carbamazepine-viloxazine interaction in patients with epilepsy. J Neurol Neurosurg Psychiatry 1986;49:1142-5.
23. Pearson HJ. Interaction of fluoxetine with carbamazepine [letter]. J Clin Psychiatry 1990;51:126.
24. Grimsley S, Jann MW, Carter JG, D'Mello AP, D'Souza MJ. Increased carbamazepine plasma concentrations after fluoxetine co-administration. Clin Pharmacol Ther 1991;50:10-5.
25. Leinonen E, Lillsunde P, Laukkanen V, Ylitalo P. Effects of carbamazepine on serum antidepressant concentrations in psychiatric patients. J Clin Psychopharmacol 1991;11:313-8.
26. Brøsen K, Kragh-Sorensen P. Concomitant intake of nortriptyline and carbamazepine. Their Drug Monit 1193;15:258-60.
27. Brown CS, Wells BG, Cold JA, Froemming JH, Self TH, Jabbour JT. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder. J Clin Psychopharmacol 1990;10:359-62.
28. Baldessarini RJ, Teicher MH, Cassidy JW, Stein MH. Anticonvulsant cotreatment may increase toxic metabolites of antidepressants and other psychotropic drug [letter]. J Clin Psychopharmacol 1988;8:381-2.
29. de la Fuente JM, Mendlewicz J. Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression. Biol Psychiatry 1992;32:369-74.
30. Ketter TA, Jenkins JB, Schroeder DH, Pazzaglia PJ, Marangell LB, George MS, Callahan AM, Hinton ML, Clao J, Post RM. Carbamazepine but not valproate induces bupropion metabolism. J Clin Psychopharmacol 1995;15:327-33.
31. Franc JE, Duncan GF, Farmen RH, Pittman KA. High-performance liquid chromatographic method for the determination of nefazodone and its metabolites in human plasma using laboratory robotics. J Chromatogr 1991;570:129-38.
32. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, 1982.
33. Gomeni R. An interactive program for individual and population parameter estimation. Von Bommel MJ, Ball NO, eds. North Holland: Wigerts, 1983:1022-5.
34. Box GEP, Cox DR. Analysis of transformations. J Roy Stat Soc 1964;265:211-52.
35. Gill JL. Design and analysis of experiments in the animal and medical sciences. Ames, IA: The Iowa State University Press, 1978: 179-82.
36. Marshall PS, Straka RJ, Johnson K. Determination of dextromethorphan and its O-demethylated metabolite from urine. Ther Drug Monit 1992;14:402-7.
37. Ketter TA, Flockhart DA, Post RM, Denicoff K, Pazzaglia PJ, Marangeli LB, George MS, Callahan AM. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol 1995;15:387-98.
38. Otani K, Ishida M, Kaneko S, Mihara K, Ohkubo T, Osanai T, Sugawara K. Effects of carbamazepine co-administration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine. Ther Drug Monit 1996;18:164-7.
39. Keller Ashton A, Wolin RE. Nefazodone-induced carbamazepine toxicity [letter]. Am J Psychiatry 1996;153:733.
40. Perruca E, Hedges A, Makki KA, et al. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Br J Clin Pharmacol 1984;18:401-10.